Adenosine deaminase acting on RNA1 mutation in chilblain lupus treated with tofacitinib
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Familial chilblain lupus (FCL) is a rare form of monogenic cutaneous lupus presenting in childhood with recurrent, cold-induced, painful violaceous papules at acral sites oftentimes with concomitant inflammatory arthritis, Raynaud’s phenomenon, and cytopenias. As a variant of lupus erythematosus, immunofluorescent testing of lesional skin will show a positive lupus band test. FCL commonly arises from de novo mutations involving interferonopathy-related genes such as 3 prime repair exonuclease 1 (TREX1) and stimulator of interferon genes (STING), subsequently causing overactivated type-I interferon (IFN-I) signaling and autoinflammation.
Fields of Study & Subjects
Systemic Lupus Erythematosus Research
Dermatological and COVID-19 studies
Systemic Sclerosis and Related Diseases
Publication details
- Journal / source
- JAAD Case Reports
- Volume
- 72
- Pages
- 31–34
- Publication date
- 31 March 2026
- Language
- EN